News & Updates
Filter by Specialty:
Mild autonomous cortisol secretion common in women with benign adrenal tumour
Mild autonomous cortisol secretion (MACS), a cardiometabolic risk condition, mainly affects women with benign adrenal tumour and requires regular assessment for hypertension and type 2 diabetes (T2D), reveals a study.
Mild autonomous cortisol secretion common in women with benign adrenal tumour
22 Jan 2022
Metabolic syndrome linked to greater COVID-19 severity
Individuals with metabolic syndrome who are hospitalized for COVID-19 may have a greater risk for more severe COVID-19 disease, including an elevated risk of in-hospital mortality, acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission, a recent prospective study showed.
Metabolic syndrome linked to greater COVID-19 severity
21 Jan 2022
Upper extremity DVT common in COVID-19 despite proper prophylaxis
About 10 percent of patients with the coronavirus disease 2019 (COVID-19) will suffer from upper extremity deep vein thrombosis despite adequate prophylaxis, a recent study has found.
Upper extremity DVT common in COVID-19 despite proper prophylaxis
21 Jan 2022
Osteoporosis drug holidays tied to small rise in hip fracture risk
The risk for hip fracture slightly increases following osteoporosis drug holidays after long-term therapy with risedronate compared with alendronate, a study has found, adding that future research must examine how best to lessen such risk.
Osteoporosis drug holidays tied to small rise in hip fracture risk
21 Jan 2022
PSOARING trials boost potential of tapinarof for plaque psoriasis
The nonsteroidal topical aryl hydrocarbon receptor (AHR)-modulating agent tapinarof 1% trumped a vehicle control cream in reducing the severity and manifestations of plaque psoriasis, according to the phase III PSOARING 1 and 2 trials.